Breast Cancer, Familial
|
91
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2010 |
2010 |
Hypertensive disease
|
1085
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2012 |
2012 |
Renal Cell Carcinoma
|
288
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2012 |
2012 |
Intestinal metaplasia
|
24
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
|
1 |
2013 |
2013 |
Sporadic Breast Carcinoma
|
46
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2013 |
2013 |
cervical cancer
|
268
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2014 |
2014 |
Cervix carcinoma
|
283
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2014 |
2014 |
Malignant tumor of cervix
|
245
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2014 |
2014 |
Secondary malignant neoplasm of lymph node
|
188
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2014 |
2014 |
Tumor Cell Invasion
|
169
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2014 |
2014 |
Unilateral Breast Carcinoma
|
2
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2014 |
2014 |
Unilateral Breast Neoplasms
|
2
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2014 |
2014 |
Non-Small Cell Lung Carcinoma
|
712
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.030 |
1.000 |
3 |
2012 |
2015 |
Malignant neoplasm of prostate
|
1082
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2015 |
2015 |
Neoplasm Metastasis
|
327
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2015 |
2015 |
Prostate carcinoma
|
1168
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2015 |
2015 |
Secondary Neoplasm
|
85
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2015 |
2015 |
Diabetes Mellitus, Non-Insulin-Dependent
|
2672
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.030 |
1.000 |
3 |
2013 |
2016 |
Atrial Septal Defects
|
96
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2016 |
2016 |
HIV Infections
|
142
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
|
1 |
2016 |
2016 |
Obesity
|
1111
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
1.000 |
1 |
2016 |
2016 |
Carcinoma of lung
|
1204
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.030 |
0.667 |
3 |
2015 |
2017 |
Malignant neoplasm of lung
|
1142
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.030 |
0.667 |
3 |
2015 |
2017 |
Primary malignant neoplasm of lung
|
981
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.030 |
0.667 |
3 |
2015 |
2017 |
Esophageal carcinoma
|
272
|
0.623 |
0.560 |
19 |
13836478 |
non coding transcript exon variant |
T/A;C;G
|
snv |
0.34
|
0.38
|
0.010 |
|
1 |
2017 |
2017 |